Literature DB >> 30207919

Aspirin-Exacerbated Respiratory Disease.

Andrew A White1, Donald D Stevenson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30207919     DOI： 10.1056/NEJMra1712125

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

Review 1.  Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.

Authors:  Mark Rusznak; R Stokes Peebles
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-02

2.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

3.  Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

Authors:  Lauren T Roland; Heqiong Wang; C Christina Mehta; Katherine N Cahill; Tanya M Laidlaw; John M DelGaudio; Sarah K Wise; Joshua M Levy
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-23       Impact factor: 3.858

4.  Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

Authors:  Lauren T Roland; Celeste Nagy; Heqiong Wang; Renee Moore; Katherine N Cahill; Tanya M Laidlaw; Sarah K Wise; John M DelGaudio; Merin Kuruvilla; Joshua M Levy
Journal:  Int Forum Allergy Rhinol       Date:  2019-11-06       Impact factor: 3.858

5.  Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.

Authors:  Elina Jerschow; Matthew L Edin; Yuling Chi; Beth Hurst; Waleed M Abuzeid; Nadeem A Akbar; Marc Gibber; Marvin P Fried; Weiguo Han; Teresa Pelletier; Zhen Ren; Taha Keskin; Gigia Roizen; Fred B Lih; Artiom Gruzdev; J Alyce Bradbury; Victor Schuster; Simon Spivack; David Rosenstreich; Darryl C Zeldin
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

Review 6.  Immune Modulation in Asthma: Current Concepts and Future Strategies.

Authors:  Marek Lommatzsch
Journal:  Respiration       Date:  2020-06-08       Impact factor: 3.580

7.  Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps.

Authors:  Sonya Marcus; Joseph Schertzer; Lauren T Roland; Sarah K Wise; Joshua M Levy; John M DelGaudio
Journal:  Int Forum Allergy Rhinol       Date:  2019-10-10       Impact factor: 3.858

8.  Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.

Authors:  Sharan J Shah; Waleed M Abuzeid; Anusha Ponduri; Teresa Pelletier; Zhen Ren; Taha Keskin; Gigia Roizen; David Rosenstreich; Denisa Ferastraoaru; Elina Jerschow
Journal:  Int Forum Allergy Rhinol       Date:  2019-09-30       Impact factor: 3.858

Review 9.  NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.

Authors:  Tanya M Laidlaw; Joshua M Levy
Journal:  Curr Allergy Asthma Rep       Date:  2020-03-14       Impact factor: 4.806

Review 10.  Biologics in chronic rhinosinusitis with nasal polyposis.

Authors:  Tanya M Laidlaw; Kathleen M Buchheit
Journal:  Ann Allergy Asthma Immunol       Date:  2019-12-09       Impact factor: 6.347
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.